New partnership with Acticor Biotech will see patients with heart attacks treated with glenzocimab, a promising new class of drug for the first time.
‘Resistance breakers’ and better genetic tests are among new ways that scientists could address antimicrobial resistance, a new paper suggests.
The organoids provide a micro-environment that can accept and support the survival of cells from patients with blood malignancies
Blood tests will identify children likely to develop type 1 diabetes, allowing earlier, safer diagnosis
UK analysis raises need for awareness of health implications for patients following abuse and neglect
Children and adult with a rare form of bone cancer are receiving a new standard of treatment that is more effective, thanks to a CRCTU clinical trial.
The largest analysis of data on antibody therapies for protecting clinically extremely vulnerable people from Covid-19 shows that they are effective.
Some leukemias evade treatment by changing their appearance and identity through changing the read-out of their DNA, a new study has found.
Results of the clinical trial published in the Lancet found single-strand suture threads could reduce risk of infection after cerclage surgery
Lessons from the genetic mutations which led to Covid-19 variants such as Alpha and Omicron could help scientists tackle similar changes in Monkeypox.
A new trial found that an AI app-based reader for lateral flow devices reduced false Covid negatives in assisted test sites.
Renewed National Institute for Health and Care Research Birmingham Biomedical Research Centre continue funds for developments around inflammatory diseases